NEW YORK (Reuters) - Covidien Plc plans to acquire ev3 Inc for $2.6 billion to boost its business in stents and other vascular devices, underscoring the favorable deal climate in the medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback